Publications

BibTex format

@article{Patel:2021:10.1161/circgen.121.003389,
author = {Patel, PN and Ito, K and Willcox, JAL and Haghighi, A and Jang, MY and Gorham, JM and DePalma, SR and Lam, L and McDonough, B and Johnson, R and Lakdawala, NK and Roberts, A and Barton, PJR and Cook, SA and Fatkin, D and Seidman, CE and Seidman, JG},
doi = {10.1161/circgen.121.003389},
journal = {Circulation: Genomic and Precision Medicine},
pages = {1--10},
title = {Contribution of noncanonical splice variants to TTN truncating variants cardiomyopathy},
url = {http://dx.doi.org/10.1161/circgen.121.003389},
volume = {14},
year = {2021}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Background:Heterozygous TTN truncating variants cause 10% to 20% of idiopathic dilated cardiomyopathy (DCM). Although variants which disrupt canonical splice signals (ie, invariant dinucleotide of splice donor site, invariant dinucleotide of the splice acceptor site) at exon-intron junctions are readily recognized as TTN truncating variants, the effects of other nearby sequence variations on splicing and their contribution to disease is uncertain.Methods:Rare variants of unknown significance located in the splice regions of highly expressed TTN exons from 203 DCM cases, 3329 normal subjects, and clinical variant databases were identified. The effects of these variants on splicing were assessed using an in vitro splice assay.Results:Splice-altering variants of unknown significance were enriched in DCM cases over controls and present in 2% of DCM patients (P=0.002). Application of this method to clinical variant databases demonstrated 20% of similar variants of unknown significance in TTN splice regions affect splicing. Noncanonical splice-altering variants were most frequently located at position +5 of the donor site (P=4.4×107) and position -3 of the acceptor site (P=0.002). SpliceAI, an emerging in silico prediction tool, had a high positive predictive value (86%–95%) but poor sensitivity (15%–50%) for the detection of splice-altering variants. Alternate exons spliced out of most TTN transcripts frequently lacked the consensus base at +5 donor and −3 acceptor positions.Conclusions:Noncanonical splice-altering variants in TTN explain 1-2% of DCM and offer a 10-20% increase in the diagnostic power of TTN sequencing in this disease. These data suggest rules that may improve efforts to detect splice-altering variants in other genes and may explain the low percent splicing observed for many alternate TTN exons.
AU  - Patel,PN
AU  - Ito,K
AU  - Willcox,JAL
AU  - Haghighi,A
AU  - Jang,MY
AU  - Gorham,JM
AU  - DePalma,SR
AU  - Lam,L
AU  - McDonough,B
AU  - Johnson,R
AU  - Lakdawala,NK
AU  - Roberts,A
AU  - Barton,PJR
AU  - Cook,SA
AU  - Fatkin,D
AU  - Seidman,CE
AU  - Seidman,JG
DO  - 10.1161/circgen.121.003389
EP  - 10
PY  - 2021///
SN  - 2574-8300
SP  - 1
TI  - Contribution of noncanonical splice variants to TTN truncating variants cardiomyopathy
T2  - Circulation: Genomic and Precision Medicine
UR  - http://dx.doi.org/10.1161/circgen.121.003389
UR  - https://www.ahajournals.org/doi/10.1161/CIRCGEN.121.003389
UR  - http://hdl.handle.net/10044/1/91417
VL  - 14
ER  -

Download

DrPaulBarton

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)